Cancer
Malignant Esophageal Neoplasm
CI-CAN-00001127Explore in graph →
Top-level518 active trials6 approved drugs12 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001127Explore in graph →
Clinical trials
1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (169)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02209415 | EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer(EUFURO) | unknown | N/A | 182 | Michael Bau MortensenOTHER | 1 | Aug 5, 2014 | clinicaltrials |
| NCT02205463 | KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer | withdrawn | Phase 1 | 0 | NYU Langone HealthOTHER | 1 | Aug 1, 2014 | clinicaltrials |
| NCT01258192 | Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients(nabPCESCC) | completed | Phase 2 | 35 | Zhejiang Cancer HospitalOTHER | 1 | Jul 29, 2014 | clinicaltrials |
| NCT01627080 | Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and Radiation | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 28, 2014 | clinicaltrials |
| NCT01447927 | Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus | completed | Phase 2 | 93 | National Cancer Institute (NCI)NIH | 3 | Jul 21, 2014 | clinicaltrials |
| NCT02188615 | Study of Neo-adjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Squamous Cell Esophageal Cancer(NACRFMIE) | unknown | Phase 2 | 120 | Chengchu ZhuOTHER | 1 | Jul 11, 2014 | clinicaltrials |
| NCT00313599 | Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 28 | University of California, San FranciscoOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT00474903 | Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus | completed | Phase 2 | 122 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2014 | clinicaltrials |
| NCT02017002 | Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal Cancer | unknown | N/A | 100 | National Taiwan University HospitalOTHER | 1 | Jun 30, 2014 | clinicaltrials |
| NCT00004236 | Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer | unknown | Phase 2 | — | University of LeicesterOTHER | 1 | Jun 24, 2014 | clinicaltrials |
| NCT00183807 | A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer | terminated | Phase 2 | 6 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00021320 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | completed | Phase 2 | 21 | Fox Chase Cancer CenterOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT00290719 | Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery | terminated | Phase 1 | 6 | University of California, San FranciscoOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT01444547 | A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin | unknown | Phase 2 | 92 | Chinese Academy of Medical SciencesOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT00425425 | Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer | unknown | Phase 1 / Phase 2 | 43 | Technical University of MunichOTHER | 1 | May 1, 2014 | clinicaltrials |
| NCT00686114 | Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal Cancer | unknown | Phase 3 | 344 | Wenzhou Medical UniversityOTHER | 1 | Apr 29, 2014 | clinicaltrials |
| NCT01952210 | Effectiveness of a Nutritional Consultation and Exercise Program in Esophageal Cancer Patient | completed | N/A | 56 | National Taiwan University HospitalOTHER | 1 | Apr 23, 2014 | clinicaltrials |
| NCT01957241 | PLA for HCC and Esophageal ca Serum | unknown | — | 164 | National Taiwan University HospitalOTHER | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01927978 | Using "PET Response Criteria in Solid Tumors (PERCIST)" in Evaluating Response to Neoadjuvant Chemoradiotherpy for Esophageal Cancer | unknown | — | 60 | National Taiwan University HospitalOTHER | 1 | Apr 15, 2014 | clinicaltrials |
| NCT02094105 | Endoscopic Screening on Esophageal Cancer | completed | N/A | 45,386 | Chinese Academy of Medical SciencesOTHER | 1 | Mar 21, 2014 | clinicaltrials |
| NCT00101907 | Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer | terminated | Phase 1 | 41 | AmgenINDUSTRY | 0 | Mar 20, 2014 | clinicaltrials |
| NCT00619242 | The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer(Barrett's) | terminated | N/A | 3 | University of ChicagoOTHER | 1 | Mar 12, 2014 | clinicaltrials |
| NCT00416858 | Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery | completed | Phase 3 | 40 | Federation Francophone de Cancerologie DigestiveOTHER | 0 | Mar 4, 2014 | clinicaltrials |
| NCT01256203 | Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light | withdrawn | Phase 2 | 0 | Pinnacle Biologics Inc.INDUSTRY | 0 | Mar 4, 2014 | clinicaltrials |
| NCT02074124 | CT Perfusion Changes in GI Cancer During Adenosine Vasodilation Test | completed | — | 15 | University of CopenhagenOTHER | 1 | Feb 28, 2014 | clinicaltrials |
| NCT00113581 | Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer | completed | Phase 1 | 26 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Feb 19, 2014 | clinicaltrials |
| NCT00903136 | Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus | unknown | Phase 1 / Phase 2 | 50 | US Department of Veterans AffairsFED | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00281736 | Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer | completed | Phase 2 | 60 | Roswell Park Cancer InstituteOTHER | 1 | Jan 3, 2014 | clinicaltrials |
| NCT00005607 | Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus | unknown | Phase 2 | — | Robert H. Lurie Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00010270 | LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | unknown | Phase 1 | 50 | University Hospital FreiburgOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00072332 | Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT02016274 | Sequential Paclitaxel Plus Cisplatin Chemotherapy and Radiotherapy as 1st Line Treatment for Esophageal Squamous Cell Cancer | unknown | Phase 2 | 70 | Shen LinOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT02016287 | Sequential Paclitaxel Chemotherapy and Radiotherapy as 1st Line Treatment for Elderly Esophageal Squamous Cell Cancer | unknown | Phase 2 | 50 | Shen LinOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00719550 | AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer | completed | Phase 1 / Phase 2 | 130 | AmgenINDUSTRY | 0 | Dec 5, 2013 | clinicaltrials |
| NCT00005876 | Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery | unknown | Phase 2 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00470184 | Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer | completed | Phase 2 | 41 | Roswell Park Cancer InstituteOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01993784 | Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma. | unknown | Phase 1 / Phase 2 | 9 | Peking UniversityOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT00002631 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus | completed | Phase 3 | 298 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 19, 2013 | clinicaltrials |
| NCT00636298 | Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy | withdrawn | Phase 2 | 0 | Emory UniversityOTHER | 0 | Nov 19, 2013 | clinicaltrials |
| NCT00258297 | Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery | terminated | Phase 2 | 30 | University of RochesterOTHER | 1 | Oct 16, 2013 | clinicaltrials |
| NCT01962272 | The Effect of Nutritional Counseling for Cancer Patients | completed | Phase 4 | 61 | University of CopenhagenOTHER | 1 | Oct 14, 2013 | clinicaltrials |
| NCT00086996 | S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction | completed | Phase 2 | 98 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 11, 2013 | clinicaltrials |
| NCT01959906 | Circumferential Section Pane Less Than 1 mm in Esophagectomy for Esophageal Cancer. | unknown | — | 923 | University Hospital, GasthuisbergOTHER | 1 | Oct 10, 2013 | clinicaltrials |
| NCT01958697 | Age and Gender Corrected Body Mass Index | unknown | — | 650 | University Hospital, GasthuisbergOTHER | 1 | Oct 9, 2013 | clinicaltrials |
| NCT00077545 | 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT01705340 | Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery | terminated | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00002897 | Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus | completed | Phase 3 | 240 | European Institute of OncologyOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00566800 | Erlotinib in Treating Patients With Barrett Esophagus | unknown | Phase 1 | 25 | Kansas City Veteran Affairs Medical CenterFED | 1 | Sep 17, 2013 | clinicaltrials |
| NCT01937208 | Comparable Study of Different Radiation Dose in Esophageal Carcinoma | unknown | Phase 3 | 300 | Zhejiang Cancer HospitalOTHER | 1 | Sep 9, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Aug 5, 2014source: clinicaltrials